Bromodiphenhydramine: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
(One intermediate revision by the same user not shown)
Line 28: Line 28:
{{CMG}}
{{CMG}}


{{Editor Help}}
 


==Overview==
==Overview==
Line 36: Line 36:


[[Category:H1 receptor antagonists]]
[[Category:H1 receptor antagonists]]
{{SIB}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 23:11, 8 August 2012

Bromodiphenhydramine
Clinical data
Routes of
administration
Oral
ATC code
Pharmacokinetic data
BioavailabilityHigh
Protein binding96%
MetabolismMostly hepatic (CYP-mediated), also renal
Elimination half-life1 to 4 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H20BrNO
Molar mass334.251 g/mol
3D model (JSmol)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Bromazine (INN, also known as bromodiphenhydramine) is an antihistamine. It is a brominated derivative of diphenhydramine. The medicinal preparation of the hydrochloride has the brand name Ambrodyl


Template:WikiDoc Sources